𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy

✍ Scribed by Vanessa Gonçalves Pereira; Ana Maria Martins; Cecília Micheletti; Vânia D'Almeida

Book ID
116347735
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
144 KB
Volume
387
Category
Article
ISSN
0009-8981

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutational analysis of mucopolysaccharid
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy
✍ L. Karageorgos; P. Harmatz; J. Simon; A. Pollard; P. R. Clements; D. A. Brooks; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Communicated by Andreas Gal Mucopolysaccharidosis type VI (MPS VI), or Maroteaux-Lamy syndrome, is a lysosomal storage disorder caused by a deficiency of N-acetylgalactosamine-4-sulfatase (ARSB). Seven MPS VI patients were chosen for the initial clinical trial of enzyme replacement therapy. Dir

Identification and molecular characteriz
Identification and molecular characterization of α-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy
✍ G. Yogalingam; X.-H. Guo; V.J. Muller; D.A. Brooks; P.R. Clements; E.D. Kakkis; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 1 views

Mucopolysaccharidosis type I (MPS I) is an autosomal recessive lysosomal storage disorder caused by a deficiency of alpha-L-iduronidase (IDUA). Mutations in the gene are responsible for the enzyme deficiency, which leads to the intralysosomal storage of the partially degraded glycosaminoglycans derm